Revenue
2022
2023
2024
2025
Orchestra BioMed Holdings, Inc. (OBIO)
Price$4.95Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $33.5M | $2.6M | $2.8M | $3.5M | — | — |
| Gross profit | $33.3M | $2.4M | $2.6M | $3.3M | — | — |
| Gross margin | 99.43% | 92.27% | 93.26% | 94.03% | — | — |
| Research & development | $58.2M | $42.8M | $33.8M | $21.9M | — | — |
| Operating expenses | $85.3M | $66.9M | $54.3M | $36.2M | — | $179,986 |
| Operating income | −$51.8M | −$64.3M | −$51.5M | −$32.7M | −$394,756 | — |
| Operating margin | −154.73% | −2,437.49% | −1,866.16% | −924.34% | — | — |
| EBITDA | −$51.5M | −$64.0M | −$51.2M | −$32.4M | — | — |
| EBITDA margin | −153.75% | −2,425.82% | −1,855.76% | −918.06% | — | — |
| Net income | −$52.7M | −$61.0M | −$49.1M | −$33.6M | −$378,753 | −$173,542 |
| Net profit margin | −157.40% | −2,313.27% | −1,779.71% | −951.26% | — | — |
| Basic EPSper basic share | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 | $0.00 |
| Diluted EPSper diluted share | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 | $0.00 |
Owners
Reported shareholders
15.90%of listed shares
RTW INVESTMENTS, LP9.56M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
RTW INVESTMENTS, LP | 15.90%9.56M shares |
PERCEPTIVE ADVISORS LLC | 8.38%5.04M shares |
BlackRock, Inc. | 4.18%2.51M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.37%2.02M shares |
HSAC 2 Holdings, LLC | ≈2.84%1.71M shares |
Hochman David P | ≈2.51%1.51M shares |
Sherman Darren | ≈1.97%1.18M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.68%1.01M shares |
Alyeska Investment Group, L.P. | 1.66%1M shares |
Propel Bio Management, LLC | 1.49%896.7K shares |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.07%642.15K shares |
Taylor Andrew Lawrence | ≈0.99%593.07K shares |
STATE STREET CORP | 0.86%516.05K shares |
RICE HALL JAMES & ASSOCIATES, LLC | 0.71%424K shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.58%349.54K shares |
NORTHERN TRUST CORP | 0.57%343.64K shares |
UBS Group AG | 0.54%325.77K shares |
VANGUARD FIDUCIARY TRUST CO | 0.49%292.25K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.46%274.97K shares |
Knott David M Jr | 0.42%253.65K shares |
Percentages use 60.11M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026Form 4 | Hochman David PSee Remarks | BuyCommon Stock, par value $0.0001 per share ("Common Stock") | 5.0K | $3.83 | $19.1K | 1.06M |
| Jun 1, 2026Form 4 · 10b5-1 | Sherman DarrenSee Remarks | SellCommon Stock, par value $0.0001 per share | 15.0K | $3.87 | $58.0K | 1.18M |
| May 18, 2026Form 4 | Aryeh JasonDirector | BuyCommon Stock, par value $0.0001 per share | 665 | $3.75 | $2.5K | 118.1K |
| May 15, 2026Form 4 | Aryeh JasonDirector | BuyCommon Stock, par value $0.0001 per share | 9.0K | $3.90 | $35.0K | 117.5K |
| May 15, 2026Form 4 | Hochman David PSee Remarks | BuyCommon Stock, par value $0.0001 per share ("Common Stock") | 5.0K | $3.77 | $18.9K | 1.06M |